P450 enzymes and Parkinson's disease: The story so far
Identifieur interne : 003672 ( Istex/Checkpoint ); précédent : 003671; suivant : 003673P450 enzymes and Parkinson's disease: The story so far
Auteurs : Andrew G. Riedl [Royaume-Uni] ; Paul M. Watts [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-03.
English descriptors
- KwdEn :
Abstract
Environmental or endogenous toxins may cause nigral cell death in Parkinson's disease (PD) as a result of genetic susceptibility conferred by altered expression of P450 enzymes. Attention over the last 10 years has focused on CYP2D6 polymorphisms and susceptibility to PD. This review summarizes reports arising from both phenotypic and genotypic studies involving CYP2D6 and PD. Phenotypic studies have failed to support a link between CYP2D6 and PD. The more powerful genetic studies initially indicated a link between CYP2D6B mutations and PD, but critical analysis of the literature and recent studies emerging from independent laboratories fail to confirm this. Mutations in CYP2D6B are also not implicated in familial PD. As yet, there is no conclusive evidence to suggest that CYP2D6 polymorphisms confer susceptibility to PD. Whether polymorphisms in other P450s (for example, CYP1A1 and CYP2E1) are implicated in PD remains to be established.
Url:
DOI: 10.1002/mds.870130204
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:345F9285D2146769294488D56F23E8836392B787Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">P450 enzymes and Parkinson's disease: The story so far</title>
<author><name sortKey="Riedl, Andrew G" sort="Riedl, Andrew G" uniqKey="Riedl A" first="Andrew G." last="Riedl">Andrew G. Riedl</name>
</author>
<author><name sortKey="Watts, Paul M" sort="Watts, Paul M" uniqKey="Watts P" first="Paul M." last="Watts">Paul M. Watts</name>
</author>
<author><name sortKey="Jenner" sort="Jenner" uniqKey="Jenner" last="Jenner">Jenner</name>
</author>
<author><name sortKey="David Marsden, C" sort="David Marsden, C" uniqKey="David Marsden C" first="C." last="David Marsden">C. David Marsden</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:345F9285D2146769294488D56F23E8836392B787</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130204</idno>
<idno type="url">https://api.istex.fr/document/345F9285D2146769294488D56F23E8836392B787/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F62</idno>
<idno type="wicri:Area/Istex/Curation">000F62</idno>
<idno type="wicri:Area/Istex/Checkpoint">003672</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">P450 enzymes and Parkinson's disease: The story so far</title>
<author><name sortKey="Riedl, Andrew G" sort="Riedl, Andrew G" uniqKey="Riedl A" first="Andrew G." last="Riedl">Andrew G. Riedl</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Neurodegenerative Disease Research Centre, Pharmacology Group, King's College, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Watts, Paul M" sort="Watts, Paul M" uniqKey="Watts P" first="Paul M." last="Watts">Paul M. Watts</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Neurodegenerative Disease Research Centre, Pharmacology Group, King's College, London</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Jenner" sort="Jenner" uniqKey="Jenner" last="Jenner">Jenner</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Neurodegenerative Disease Research Centre, Pharmacology Group, King's College, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="David Marsden, C" sort="David Marsden, C" uniqKey="David Marsden C" first="C." last="David Marsden">C. David Marsden</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-03">1998-03</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="212">212</biblScope>
<biblScope unit="page" to="220">220</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">345F9285D2146769294488D56F23E8836392B787</idno>
<idno type="DOI">10.1002/mds.870130204</idno>
<idno type="ArticleID">MDS870130204</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CYP2D6</term>
<term>Debrisoquine</term>
<term>P450</term>
<term>Parkinson's disease</term>
<term>Polymorphisms</term>
<term>Young‐onset Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Environmental or endogenous toxins may cause nigral cell death in Parkinson's disease (PD) as a result of genetic susceptibility conferred by altered expression of P450 enzymes. Attention over the last 10 years has focused on CYP2D6 polymorphisms and susceptibility to PD. This review summarizes reports arising from both phenotypic and genotypic studies involving CYP2D6 and PD. Phenotypic studies have failed to support a link between CYP2D6 and PD. The more powerful genetic studies initially indicated a link between CYP2D6B mutations and PD, but critical analysis of the literature and recent studies emerging from independent laboratories fail to confirm this. Mutations in CYP2D6B are also not implicated in familial PD. As yet, there is no conclusive evidence to suggest that CYP2D6 polymorphisms confer susceptibility to PD. Whether polymorphisms in other P450s (for example, CYP1A1 and CYP2E1) are implicated in PD remains to be established.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
</region>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Riedl, Andrew G" sort="Riedl, Andrew G" uniqKey="Riedl A" first="Andrew G." last="Riedl">Andrew G. Riedl</name>
</region>
<name sortKey="David Marsden, C" sort="David Marsden, C" uniqKey="David Marsden C" first="C." last="David Marsden">C. David Marsden</name>
<name sortKey="Jenner" sort="Jenner" uniqKey="Jenner" last="Jenner">Jenner</name>
<name sortKey="Watts, Paul M" sort="Watts, Paul M" uniqKey="Watts P" first="Paul M." last="Watts">Paul M. Watts</name>
<name sortKey="Watts, Paul M" sort="Watts, Paul M" uniqKey="Watts P" first="Paul M." last="Watts">Paul M. Watts</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003672 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 003672 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:345F9285D2146769294488D56F23E8836392B787 |texte= P450 enzymes and Parkinson's disease: The story so far }}
This area was generated with Dilib version V0.6.23. |